PFE Stock Analysis: Buy, Sell, or Hold?
PFE - Pfizer Inc.
$25.69
0.35 (1.38%)
▲
5d:
-1.72%
30d:
-2.87%
90d:
-3.46%
BUY
HIGH Confidence
Analysis Updated: Jun 4, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.8/10
Get Alerted When PFE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called PFE this week
86% bullish • 1 bearish
86% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PFE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: PFE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.63
Based on -0.1% avg growth
INTRINSIC VALUE TODAY
$15.92
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PFE is currently trading at $25.69, which is considered slightly low relative to its 30-day fair value range of $25.59 to $26.40. The stock's valuation (Forward PE: 9.1) is in line with its historical norms (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PFE is in a uptrend. The price is currently testing key support at $25.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.19 (+13.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PFE is in a uptrend. The price is currently testing key support at $25.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.19 (+13.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$25.59 -
$26.40
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($29.19)
Trading Range Analysis
30-Day Trading Range
$25.59 -
$26.40
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$25.27
Resistance Level
$26.54
Current Trend
Uptrend
Technical data as of
Jun 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.06
Wall Street Target
$29.19
(+13.6%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
-10.1%
Profit Margin
11.8%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
9.1 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$25.64
(0%)
2-Year Target
$25.59
(0%)
3-Year Target
$25.54
(-1%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
$25.66
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: -4.2%)
$54.64
(+113%)
Base:
(SPY PE: 9.1, Growth: -4.2%)
$22.58
(-12%)
Bear:
(PE: 7.7, Growth: -4.2%)
$19.19
(-25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 19.34 | Current EPS (TTM): $1.31
Bull Case
$55.75
(+117%)
Analyst growth 100.0%, PE expands to 21.3
Base Case
$50.68
(+97%)
Market implied 100.0%, PE stable at 19.3
Bear Case
$17.23
(-33%)
Severe decline -20.0%, PE contracts to 16.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.1 to 9.1
Stabilization Target:
$25.82
(+0.5%)
PE Expansion Potential:
+0.5%
Share & Embed Analysis
Last updated: June 05, 2026 8:08 AM ET
Data refreshes hourly during market hours. Next update: 9:08 AM
Data refreshes hourly during market hours. Next update: 9:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PFE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2026-03-13
Gilbert Ray Cisneros, Jr.
BUY
2026-02-10
Ro Khanna
SELL
2026-01-22
Featured in Portfolios
PFE is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1211 | 63 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 59 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$253 | 69 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$352 | 64 BUY |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$130 | 67 BUY |
Advanced PFE Option Strategies
Professional options setups generated by AI based on today's PFE price and gamma walls.
